Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
21.93B | 21.31B | 17.87B | 14.30B | 13.12B | Gross Profit |
21.93B | 21.31B | 17.87B | 14.30B | 13.12B | EBIT |
0.00 | 11.27B | 15.83B | 7.87B | 3.65B | EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Net Income Common Stockholders |
7.63B | 7.36B | 6.53B | 4.91B | 2.06B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
117.05B | 107.11B | 133.42B | 189.28B | 138.71B | Total Assets |
720.84B | 686.53B | 665.35B | 638.78B | 539.60B | Total Debt |
0.00 | 22.36B | 27.47B | 26.27B | 24.28B | Net Debt |
-117.05B | -85.37B | -105.95B | -163.02B | -114.44B | Total Liabilities |
662.69B | 634.10B | 618.85B | 596.03B | 499.70B | Stockholders Equity |
58.15B | 52.43B | 46.50B | 42.73B | 39.87B |
Cash Flow | Free Cash Flow | |||
8.85B | -1.41B | -568.00M | 4.29B | 2.12B | Operating Cash Flow |
9.83B | -437.00M | 132.00M | 5.18B | 2.80B | Investing Cash Flow |
-27.01B | -27.15B | -67.97B | -45.87B | -23.21B | Financing Cash Flow |
26.47B | 1.96B | 10.55B | 91.97B | 73.86B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $19.48B | 9.61 | 13.51% | 2.25% | 14.47% | 3.22% | |
77 Outperform | $15.04B | 11.40 | 23.88% | 5.30% | -16.96% | -10.73% | |
77 Outperform | $24.78B | 8.81 | 9.39% | 2.93% | 10.29% | -5.75% | |
70 Outperform | $23.76B | 7.96 | 10.44% | 1.27% | -8.55% | 13.58% | |
70 Outperform | $19.02B | 15.46 | 11.61% | 4.12% | -3.94% | 31.52% | |
69 Neutral | $19.20B | 5.77 | 8.57% | 3.52% | 12.26% | 4.95% | |
64 Neutral | $12.52B | 9.82 | 7.95% | 16985.69% | 12.70% | -4.60% |